Establishment Labs Holdings (ESTA) Asset Writedowns and Impairment (2017 - 2026)
Establishment Labs Holdings (ESTA) posted quarterly Asset Writedowns and Impairment of $1.3 million for Q1 2026, down 24.68% year-over-year from $1.7 million in Q1 2025, and up 1115.62% quarter-over-quarter from -$128000.0 in Q4 2025.
Establishment Labs Holdings (ESTA) Asset Writedowns and Impairment (2017 - 2026) Analysis & Trends
Establishment Labs Holdings' Asset Writedowns and Impairment history runs 10 years deep, the most recent figure standing at $1.3 million for Q1 2026.
- In Q1 2026, Asset Writedowns and Impairment fell 24.68% year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $2.2 million (down 30.03% YoY), while the FY2025 annual figure was $2.6 million, up 53.66% from the prior year.
- Asset Writedowns and Impairment for Q1 2026 stood at $1.3 million, up from -$128000.0 in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $1.7 million in Q1 2025, with the low at -$1.3 million in Q2 2022.
- The 5-year median for Asset Writedowns and Impairment is $282000.0 (2023), against an average of $498117.6.
- Peak annual rise in Asset Writedowns and Impairment reached 23483.33% in 2022, while the deepest fall reached 1185.34% in 2022.
- Establishment Labs Holdings' Asset Writedowns and Impairment stood at $90000.0 in 2022, then surged by 85.56% to $167000.0 in 2023, then surged by 456.29% to $929000.0 in 2024, then slumped by 113.78% to -$128000.0 in 2025, then surged by 1115.62% to $1.3 million in 2026.
- Business Quant data shows ESTA's Asset Writedowns and Impairment at $1.3 million in Q1 2026, -$128000.0 in Q4 2025, and $810000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn |
| 10 | Establishment Labs Holdings | 2.16 Bn | 2.09 Bn | 47.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.51 Mn |
| Jun 30, 2026 | -1.51 Mn |
| Mar 31, 2026 | 1.30 Mn |
| Mar 31, 2026 | 1.30 Mn |
| Dec 31, 2025 | -128,000.00 |
| Dec 31, 2025 | -128,000.00 |
| Sep 30, 2025 | 810,000.00 |
| Sep 30, 2025 | 810,000.00 |
| Jun 30, 2025 | 238,000.00 |
| Jun 30, 2025 | 238,000.00 |
| Mar 31, 2025 | 1.73 Mn |
| Mar 31, 2025 | 1.73 Mn |
| Dec 31, 2024 | 929,000.00 |
| Dec 31, 2024 | 929,000.00 |
| Sep 30, 2024 | 440,000.00 |
| Sep 30, 2024 | 440,000.00 |
| Jun 30, 2024 | 78,000.00 |
| Jun 30, 2024 | 78,000.00 |
| Mar 31, 2024 | 275,000.00 |
| Mar 31, 2024 | 275,000.00 |